AUKETT SWANKE GROUP PLC
AUK | IL
Overview
Corporate Details
- ISIN(s):
- GB0000617950
- LEI:
- 213800WWNHLPUBSUK220
- Country:
- United Kingdom
- Address:
- 10 BONHILL STREET, EC2A 4PE LONDON
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Avacta Group plc is a UK life sciences company focused on improving healthcare through targeted cancer treatments and diagnostics.Ê They utilize Affimer and pre|CISION platforms to develop safe and effective drugs and research tools.Ê Their strategy centers on oncology, including partnerships to expand targeted cancer therapies.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-26 17:40 |
Declaration of Voting Results & Voting Rights Announcements
Result of Annual General Meeting
|
English | 26.3 KB | |
| 2025-05-27 16:15 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 52.6 KB | |
| 2025-03-03 11:30 |
Regulatory News Service
Change of Name
|
English | 14.7 KB | |
| 2025-01-14 12:15 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 52.4 KB | |
| 2024-12-05 14:08 |
Transaction in Own Shares
Director and PCA Dealings
|
English | 37.0 KB | |
| 2024-11-28 08:00 |
Regulatory News Service
Notice of presence at Anticipate London 2024
|
English | 14.9 KB | |
| 2024-11-14 08:00 |
Regulatory News Service
Change of Auditor
|
English | 10.4 KB | |
| 2024-09-18 08:00 |
Business and Financial Review
Property disposal completion & Corporate update
|
English | 19.3 KB | |
| 2024-08-20 18:15 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 52.4 KB | |
| 2024-08-20 14:15 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 21.9 KB | |
| 2024-08-06 18:30 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 52.4 KB | |
| 2024-08-01 11:00 |
Directors' Dealings
Director Dealing
|
English | 27.2 KB | |
| 2024-07-17 08:00 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 21.9 KB | |
| 2024-07-15 14:00 |
Directors' Dealings
AIM Rule 17 - Schedule 2(g) Update
|
English | 12.5 KB | |
| 2024-07-05 17:25 |
Capital/Financing Update
Property Disposal Update
|
English | 12.8 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Toleranzia AB | Sweden | TOL | |
|
Transgene | France | TNG | |
|
Tvardi Therapeutics Inc. | United States of America | TVRD | |
|
Ulisse Biomed | Italy | UBM | |
|
Univo Pharmaceuticals Ltd. | Israel | UNVO-M | |
|
Urteste S.A. | Poland | URT | |
|
Valbiotis | France | ALVAL | |
|
VALIRX PLC | United Kingdom | VAL | |
|
Vaxxa AB | Sweden | VAXXA | |
| Vision Sigma Ltd. | Israel | VISN |